Zulresso

Active Ingredient(s): Brexanolone
FDA Approved: * March 19, 2019
Pharm Company: * SAGE THERAPEUTICS

Allopregnanolone is a naturally occurring neurosteroid which is made in the body from the hormone progesterone.[9][10] As a medication, allopregnanolone is referred to as brexanolone, sold under the brand name Zulresso,[6][11] and used to treat postpartum depression.[10][12][13] It is used by injection into a vein over a 60-hour period under medical supervision.[10]&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zulresso 5 mg/ml Intravenous Injection, Solution
NDC: 72152-547
Labeler:
Sage Therapeutics, Inc.